Rational nanotoolbox with theranostic potential for medicated pro-regenerative corneal implants

Cornea diseases are a leading cause of blindness and the disease burden is exacerbated by the increasing shortage around the world for cadaveric donor corneas. Despite the advances in the field of regenerative medicine, successful transplantation of laboratory made artificial corneas has not been fully realised in clinical practice. The causes of failure of such artificial corneal implants are multifactorial and include latent infections from viruses and other micorbes, enzyme over-expression, implant degradation, extrusion or delayed epithelial regeneration. Therefore, there is an urgent unmet need for developing customized corneal implants to suit the host environment, counter the effects of inflammation or infection and that are able to track early signs of implant failure in situ. In the present work, we describe a nano toolbox comprising tools for drug release and in addition capable of being infection responsive, promoting regeneration including non-invasive monitoring of in situ corneal environment. These nano constructs can be incorporated within pro-regenerative biosynthetic implants, transforming them into theranostic devices able to respond to biological changes following implantation.

[1]  R. Champlin,et al.  Delay of alternative antiviral therapy and poor outcomes of acyclovir‐resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant – a retrospective study , 2018, Transplant international : official journal of the European Society for Organ Transplantation.

[2]  Chaoliang He,et al.  Biomaterials-enabled cornea regeneration in patients at high risk for rejection of donor tissue transplantation , 2018, npj Regenerative Medicine.

[3]  A. Kheirkhah,et al.  Management of high-risk corneal transplantation. , 2017, Survey of ophthalmology.

[4]  A. Zherdev,et al.  Less is More: A Comparison of Antibody-Gold Nanoparticle Conjugates of Different Ratios. , 2017, Bioconjugate chemistry.

[5]  M. Minhas,et al.  FORMULATION AND IN VITRO EVALUATION OF ACYCLOVIR LOADED POLYMERIC MICROPARTICLES: A SOLUBILITY ENHANCEMENT STUDY. , 2016, Acta poloniae pharmaceutica.

[6]  Gilles Thuret,et al.  Global Survey of Corneal Transplantation and Eye Banking. , 2016, JAMA ophthalmology.

[7]  S. Wechsler,et al.  Confocal Microscopic Analysis of a Rabbit Eye Model of High-Incidence Recurrent Herpes Stromal Keratitis , 2016, Cornea.

[8]  A. Turner,et al.  Surface-Engineered Contact Lens as an Advanced Theranostic Platform for Modulation and Detection of Viral Infection. , 2015, ACS applied materials & interfaces.

[9]  A. Tiwari,et al.  Advanced Theranostic Materials: Tiwari/Advanced , 2015 .

[10]  Mark I Rosenblatt,et al.  Boston Keratoprosthesis: Outcomes and Complications: A Report by the American Academy of Ophthalmology. , 2015, Ophthalmology.

[11]  Helen E. Smith,et al.  Keratoprostheses for corneal blindness: a review of contemporary devices , 2015, Clinical ophthalmology.

[12]  S. Eberhardt,et al.  Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation. , 2015, AJR. American journal of roentgenology.

[13]  Chaoliang He,et al.  Functional fabrication of recombinant human collagen-phosphorylcholine hydrogels for regenerative medicine applications. , 2015, Acta biomaterialia.

[14]  Emily B. Ehlerding,et al.  Theranostic Nanoparticles , 2014, The Journal of Nuclear Medicine.

[15]  Christopher Liu,et al.  A brief review of Boston type-1 and osteo-odonto keratoprostheses , 2014, British Journal of Ophthalmology.

[16]  M. A. Palafox,et al.  Conformational Analysis, Molecular Structure and Solid State Simulation of the Antiviral Drug Acyclovir (Zovirax) Using Density Functional Theory Methods , 2014, Pharmaceuticals.

[17]  V. Chopra,et al.  Glaucoma management in Boston keratoprosthesis type I recipients , 2014, Current opinion in ophthalmology.

[18]  Isabelle Brunette,et al.  Stable corneal regeneration four years after implantation of a cell-free recombinant human collagen scaffold. , 2014, Biomaterials.

[19]  L. Leibler,et al.  Nanoparticle solutions as adhesives for gels and biological tissues , 2013, Nature.

[20]  A. Osterhaus,et al.  Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis. , 2013, The Journal of infectious diseases.

[21]  B. Liedberg,et al.  Epoxy Cross-Linked Collagen and Collagen-Laminin Peptide Hydrogels as Corneal Substitutes , 2013, Journal of functional biomaterials.

[22]  Robert Langer,et al.  Enhanced function of immuno-isolated islets in diabetes therapy by co-encapsulation with an anti-inflammatory drug. , 2013, Biomaterials.

[23]  Toine Hillenaar,et al.  In Vivo Confocal Microscopy expanding horizons in corneal imaging , 2012 .

[24]  A. Dasgupta,et al.  Cancer cell response to nanoparticles: criticality and optimality. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[25]  A. Signore,et al.  PET/MRI in infectious and inflammatory diseases: will it be a useful improvement? , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  J. Dey,et al.  Interaction between zwitterionic and anionic surfactants: spontaneous formation of zwitanionic vesicles. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[27]  A. Dasgupta,et al.  Dual role of nanoparticles as drug carrier and drug , 2011, Cancer nanotechnology.

[28]  C. Yi,et al.  The effects of gold nanoparticles on the proliferation, differentiation, and mineralization function of MC3T3-E1 cells in vitro , 2010 .

[29]  J. Scaiano,et al.  Controlled Release of Acyclovir Through Bioengineered Corneal Implants with Silica Nanoparticle Carriers~!2009-08-29~!2010-01-05~!2010-03-18~! , 2010 .

[30]  J. Scaiano,et al.  Controlled Release of Acyclovir Through Bioengineered Corneal Implantswith Silica Nanoparticle Carriers , 2010 .

[31]  Lauren A Austin,et al.  Dynamic light scattering as a powerful tool for gold nanoparticle bioconjugation and biomolecular binding studies. , 2009, Analytical chemistry.

[32]  A. Dasgupta,et al.  Multimodal electrophoresis of gold nanoparticles: a real time approach. , 2009, Analytica chimica acta.

[33]  D. Coster,et al.  Risk Factors for Human Corneal Graft Failure Within the Australian Corneal Graft Registry , 2008, Transplantation.

[34]  P. Rama,et al.  Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. , 2007, American journal of ophthalmology.

[35]  Jinwoo Cheon,et al.  Heterostructured magnetic nanoparticles: their versatility and high performance capabilities. , 2007, Chemical communications.

[36]  Rejean Munger,et al.  A simple, cross-linked collagen tissue substitute for corneal implantation. , 2006, Investigative ophthalmology & visual science.

[37]  B. Triggs,et al.  Histograms of oriented gradients for human detection , 2005, 2005 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (CVPR'05).

[38]  H. Sheardown,et al.  Recruitment of multiple cell lines by collagen-synthetic copolymer matrices in corneal regeneration. , 2005, Biomaterials.

[39]  Huixiang Li,et al.  Label-free colorimetric detection of specific sequences in genomic DNA amplified by the polymerase chain reaction. , 2004, Journal of the American Chemical Society.

[40]  P. Robert,et al.  Herpes simplex virus DNA in corneal transplants: Prospective study of 38 recipients , 2003, Journal of medical virology.

[41]  C. Frank,et al.  Photo-Cross-Linkable PNIPAAm Copolymers. 1. Synthesis and Characterization of Constrained Temperature-Responsive Hydrogel Layers , 2002 .

[42]  M. Böhnke,et al.  The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin , 2002, The British journal of ophthalmology.

[43]  M. Durand,et al.  Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. , 2001, Archives of ophthalmology.

[44]  P. Gans,et al.  Hyperquad simulation and speciation (HySS): a utility program for the investigation of equilibria involving soluble and partially soluble species , 1999 .

[45]  S. Kaye,et al.  Herpes simplex keratitis. , 1996, Journal of medical microbiology.

[46]  D. J. Bauer,et al.  Modifications on the heterocyclic base of acyclovir: syntheses and antiviral properties. , 1985, Journal of medicinal chemistry.

[47]  E. De Clercq,et al.  Synthesis and antiviral activity of water-soluble esters of acyclovir [9-[(2-hydroxyethoxy)methyl]guanine]. , 1983, Journal of medicinal chemistry.

[48]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[49]  Young-wook Jun,et al.  The President and Society for Analytical Chemistry Gold Medallist , 1973 .